Global Recombinant Cell Culture Supplements Market

Focus on Pricing Analysis, Product, Application, Expression System, and Region - Analysis and Forecast, 2022-2032

Published Year:
SKU:BHP0659SC
View TOCGet Free Sample
Get Customization, Data Extraction and Value Added Services with All BIS Research Reports
Know More

$5250

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Market Report Coverage

Recombinant Cell Culture Supplements Market
Forecast Period: 2022-2032
CAGR During Forecast Period: 12.24%

Global Recombinant Cell Culture Supplements Market

Base Year

2021

Market Size in 2021

$308.6 Million

Forecast Period

2022-2032

Value Projection and Estimation by 2032

$1,188.6 Million

CAGR During Forecast Period

12.24%

Number of Tables

24

Number of Pages

245

Number of Figures

176

 

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, pipeline product portfolio, and market penetration.

Companies profiled under this section include six public companies and 10 private companies.

Public companies include Abcam plc., Corning Incorporated, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., while private companies include BBI Solutions, FUJIFILM Irvine Scientific, Inc., Gemini Bioproducts, LLC, HiMedia Laboratories, InVitria, Kingfisher Biotech, Inc., Novus Biologicals, LLC, R&D Systems, Inc., Sino Biological Inc., and STEMCELL Technologies Inc.

Read More

How can this report add value to an organization?

The product segment helps the reader to understand key recombinant cell culture supplements in the market.

Product/Innovation Strategy: The product segment helps the reader to understand key recombinant cell culture supplements in the market. Additionally, it helps to understand the multiple applications for which recombinant cell culture supplements are used. Moreover, the study provides the reader with a detailed understanding of different expression systems in which recombinant cell culture supplements are used. These expression systems include mammalian, e. coli, yeast, and others.

Growth/Marketing Strategy: The global recombinant cell culture supplements market has seen major development by key players operating in the market, such as mergers and acquisitions, business expansions, and product launches and developments. The favored strategy for the companies has been business expansions. The companies are focusing on the expansion of their manufacturing facilities to optimize and enable rapid and reliable delivery of cell culture media supplements to their customers. For instance, in June 2021, Sartorius AG opened a new site in Beit Haemek, Israel, which would focus on specialty and customized cell culture media for the advanced therapies market.

Competitive Strategy: Key players in the global recombinant cell culture supplements market analyzed and profiled in the study involve recombinant cell culture supplements such as recombinant albumin, insulin, and trypsin. Moreover, a detailed competitive benchmarking of players operating in the global recombinant cell culture supplements market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as business expansions, mergers and acquisitions, and partnerships and alliances will aid the reader in understanding the untapped revenue pockets in the market.

Read More

Industry and Technology Overview

The market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032.

Global Recombinant Cell Culture Supplements Market: Industry Overview

The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032. The growth in the global recombinant cell culture supplements market is expected to be driven by the rising demand for cell culture supplements, increasing investment in life sciences research and development, as well as growing advantages of recombinant supplements over traditional animal-derived supplements.

Market Lifecycle Stage

The global recombinant cell culture market is increasing at a rapid pace. The growing need for animal-free supplements in cell culture applications is aiding the growth of the recombinant cell culture supplements market. Recombinant cell culture supplements play a crucial role in enhancing cell viability, maintaining a healthy culture, and customizing the cell culture in accordance with the needs of the individual.

Increasing demand for immunotherapy and stem cell and regenerative medicine research is one of the major opportunities in the recombinant cell culture supplements market. Several cell culture companies, and biopharmaceutical companies are working collaboratively on drug development and using recombinant cell culture supplements as a therapeutic means for applications in biological drugs. Furthermore, the market witnessed major mergers and acquisitions in the past four years. For instance, recently, in March 2022, Thermo Fisher Scientific Inc. acquired PeproTech, Inc., a company that specializes in the development and manufacturing of recombinant proteins, in a deal of $1.85 billion.

Figure: Global Recombinant Cell Culture Supplements Market Snapshot

Global Recombinant Cell Culture Supplements Market

Source: BIS Research Analysis

Impact

Many biopharmaceutical products are being developed by utilizing the cell culture technique. The study of cell physiology and biochemistry is made possible through laboratory cell culture, which also opens up research avenues that are challenging to pursue in vivo. Controlling variables such as the culture media, culture conditions, population density, and growth rate makes it simple to assess the effects of medications or other substances on cultured cells. Additionally, it allows analyzing the function of various genes and offers enormous potential in the field of genetics. It enables the assessment of harmful and carcinogenic chemicals on cells in the fields of oncology and virology and the comprehension of how different medications, viruses, and physical or chemical carcinogens interact. Furthermore, the recombinant cell culture has various applications, such as research on vaccines, stem cells, gene therapy, and genetic engineering, as well as the creation of protein therapies manufacturing of genetically edited proteins such as monoclonal antibodies, insulin, and hormones.

Impact of COVID-19

Due to the pandemic, governments across the globe enforced lockdowns which significantly hampered the research and clinical development of several biopharmaceutical products. Additionally, research grants were shifted toward combating SARS-CoV-2. Further, the biopharmaceutical companies, research, and academic organizations focused on the development of a novel COVID-19 vaccine. Overall, there was some disruption in the recombinant cell culture supplement supply chain and operations in 2020. However, as transportation and marketing were made more accessible, the pandemic's effects on the recombinant cell culture supplements market were minimal to non-existent. Due to the shift in emphasis toward COVID-19 testing, diagnostics, and the supply chain of serum-free or recombinant supplements for the creation of a novel vaccine for the SARS-CoV-2 virus, the companies were able to maintain their financial position.

Market Segmentation

Segmentation 1: by Product
•    Recombinant Albumin (rAlbumin)
•    Recombinant Insulin (rInsulin)
•    Recombinant Epidermal Growth Factor (rEGF)
•    Recombinant Interleukin Growth Factor (rILGF)
•    Recombinant Transferrin (rTransferrin)
•    Recombinant Trypsin (rTrypsin)
•    Recombinant Insulin-like Growth Factor (rIGF)
•    Recombinant Stem Cell Factor (rSCF)
•    Recombinant Aprotinin (rAprotinin)
•    Recombinant Lysozyme (rLysozyme)
•    Others

The global recombinant cell culture supplements market in the products segment is expected to be dominated by recombinant albumin (rAlbumin). Albumin is the major nutrient and is commonly used in all types of cell cultures. Additionally, albumin is used widely in the development of monoclonal antibodies. The increase in demand for mAbs will further increase the utilization of recombinant albumin supplements in cell culture.

Segmentation 2: by Application
•    Stem Cell and Regenerative Medicine
•    Bio-Production
•    Academic and Research Application

In 2021, the global recombinant cell culture supplements market (by application) was dominated by stem cell and regenerative medicine, with a massive market share of 47.95%. However, the fastest growing segment during the forecast period is found to be academic and research applications due to enhanced cell viability and improved batch-to-batch consistency of end products.

Segmentation 3: by Expression System
•    Mammalian
•    E. Coli
•    Yeast
•    Others

The mammalian expression system dominated the global recombinant cell culture supplements market in 2021 with a market share of 40.66%. Most biopharmaceutical companies worldwide utilize stable cell lines derived from mammalian cells to produce biologics.

Segmentation 4: by Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Rest-of-the-World

The global recombinant cell culture supplements market was dominated by North America in 2021. The growth can be attributed to the presence of prominent players in the region as well as the availability of funding and technology for recombinant cell culture supplements in the region.

Recent Developments in the Global Recombinant Cell Culture Supplements Market

•    In June 2022, Gemini Bioproducts, LLC collaborated with Avantor, Inc. to provide custom cGMP solutions to enhance the process efficiency of hydrated solutions and cell culture media to biopharmaceutical companies.
•    In May 2022, FUJIFILM Irvine Scientific, Inc. announced the completion of its new bioprocessing innovation and collaboration center in China. The new center was to enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
•    In March 2022, FUJIFILM Irvine Scientific, Inc. acquired Shenandoah Biotechnology, Inc. to further enhance and complement its cell culture solutions and expertise in bioprocessing. Furthermore, the acquisition was to provide access to Shenandoah Biotechnology, Inc.'s large portfolio of recombinant proteins, which includes cytokines and growth factors.
•    In December 2019, Sartorius AG acquired a majority stake (~50%) in the Biological Industries and further plans to acquire 20% of the shares within the next three years. This acquisition was to expand Sartorius AG's cell culture media offering and will further complement its existing product portfolio for the companies in a growing market.

Demand – Drivers and Limitations

Following are the demand drivers for the global recombinant cell culture supplements market:

•    Increasing Demand for Recombinant Cell Culture Supplements Due to their Advantages
•    Increased Funding and Investment in Research and Development for Biopharmaceutical Products in Life Sciences Sector
•    Growing Number of Mergers and Acquisitions for Expanding Recombinant Cell Culture Supplements Portfolio 
•    Push from Regulatory Bodies to Utilize Animal-Free Media Supplements in Cell Culture Process

The market is expected to face some limitations too due to the following challenges:

•    Challenging Manufacturing Process of Recombinant Proteins
•    Technical Complexities Associated with Recombinant Cell Culture Supplements

Analyst Thoughts

According to Nitish Kumar, Principal Consultant, BIS Research, "The global recombinant cell culture supplements market is an emerging market and is growing rapidly. Due to the growing demand and increasing importance of animal-free cell culture supplements, the focus of researchers and biopharmaceutical companies is now shifting toward serum-free, animal-free, or recombinant cell culture supplements. Many established companies in cell culture media supplements are entering into synergistic activities such as mergers and acquisitions and partnerships and alliances with emerging companies that are solely focused on recombinant cell culture supplements, which would help the market to grow at a faster pace in years to come.”

Read More

Table of Contents

Download this TOC

Get Free Sample

1.1    Product Definition
         1.1.1    Inclusion and Exclusion
1.2    Market Scope
         1.2.1    Scope of the Study
         1.2.2    Key Questions Answered in the Report
         1.2.3    Research Methodology
1.3    Market Overview
         1.3.1    Introduction
         1.3.2    Cell Culture: Overview
         1.3.3    Media and Supplements in Cell Culture Process
                     1.3.3.1    Serum-Free Media vs. Serum-Containing Media
                     1.3.3.2    Technological Advancements of Defined Media and Importance of Recombinant Cell Culture Supplements
         1.3.4    Overall Process: Cell Development to Biopharmaceutical Product
         1.3.5    Pricing Overview
         1.3.6    Market Footprint and Growth Potential
1.4    Market Dynamics
         1.4.1    Overview
         1.4.2    Impact Analysis
         1.4.3    Market Drivers
                     1.4.3.1    Increasing Demand for Recombinant Cell Culture Supplements Due to their Advantages
                     1.4.3.2    Increased Funding and Investment in Research and Development for Biopharmaceutical Products in Life Sciences Sector
                     1.4.3.3    Growing Number of Mergers and Acquisitions for Expanding Recombinant Cell Culture Supplements Portfolio
                     1.4.3.4    Push from Regulatory Bodies to Utilize Animal-Free Media Supplements in Cell Culture Process
         1.4.4    Market Restraints
                     1.4.4.1    Challenging Manufacturing Process of Recombinant Proteins
                     1.4.4.2    Technical Complexities Associated with Recombinant Cell Culture Supplements
         1.4.5    Market Opportunities
                     1.4.5.1    Increasing Need for Immunotherapies and Stem Cell and Regenerative Medicines
                     1.4.5.2    Increasing Preference for Serum-Free Media
1.5    Industry Analysis
         1.5.1    Regulatory Framework in the U.S.
         1.5.2    Regulatory Framework in Europe
         1.5.3    Regulatory Scenario Worldwide
1.6    COVID-19 Impact on Global Recombinant Cell Culture Supplements Market
         1.6.1    Overview
         1.6.2    Research and Clinical Development Interruption in Biopharmaceutical Products
         1.6.3    Impact on Research Funding
         1.6.4    Conclusion

2.1    Overview
2.2    Recombinant Albumin (rAlbumin)
         2.2.1    Recombinant Albumin (rAlbumin) (by Application)
2.3    Recombinant Insulin (rInsulin)
         2.3.1    Recombinant Insulin (rInsulin) (by Application)
2.4    Recombinant Epidermal Growth Factor (rEGF)
         2.4.1    Recombinant Epidermal Growth Factor (rEGF) (by Application)
2.5    Recombinant Interleukin Growth Factor (rILGF)
         2.5.1    Recombinant Interleukin Growth Factor (rILGF) (by Application)
2.6    Recombinant Transferrin (rTransferrin)
         2.6.1    Recombinant Transferrin (rTransferrin) (by Application)
2.7    Recombinant Trypsin (rTrypsin)
         2.7.1    Recombinant Trypsin (rTrypsin) (by Application)
2.8    Recombinant Insulin-like Growth Factor (rIGF)
         2.8.1    Recombinant Insulin-like Growth Factor (rIGF) (by Application)
2.9    Recombinant Stem Cell Factor (rSCF)
         2.9.1    Recombinant Stem Cell Factor (rSCF) (by Application)
2.10    Recombinant Aprotinin (rAprotinin)
           2.10.1    Recombinant Aprotinin (rAprotinin) (by Application)
2.11    Recombinant Lysozyme (rLysozyme)
           2.11.1    Recombinant Lysozyme (rLysozyme) (by Application)
2.12    Others
           2.12.1    Recombinant Transforming Growth Factor (rTGF)
           2.12.2    Recombinant Insulin-Transferrin-Selenium-Ethanolamine (rITSE)
           2.12.3    Recombinant Platelet-Derived Growth Factor (rPDGF)
           2.12.4    Recombinant Leukemia Inhibitory Factor (rLIF)
                         2.12.4.1    Others (by Application)

3.1    Overview
3.2    Stem Cell and Regenerative Medicine
         3.2.1    Stem Cell Therapies
         3.2.2    Cell Therapies
         3.2.3    Gene Therapies
3.3    Bio-Production
         3.3.1    Monoclonal Antibodies
         3.3.2    Recombinant Proteins
         3.3.3    Hormones
         3.3.4    Vaccines
         3.3.5    Other Biological Products
3.4    Academic and Research Application

4.1    Overview
4.2    Mammalian Expression System
4.3    E. coli Expression System
4.4    Yeast Expression System
4.5    Others

5.1    Overview
5.2    North America
         5.2.1    Overview
                     5.2.1.1    North America Recombinant Cell Culture Supplements Market (by Product)
         5.2.2    U.S.
         5.2.3    Canada
5.3    Europe
         5.3.1    Overview
                     5.3.1.1    Europe Recombinant Cell Culture Supplements Market (by Product)
         5.3.2    Germany
         5.3.3    U.K.
         5.3.4    France
         5.3.5    Italy
         5.3.6    Spain
         5.3.7    Rest-of-Europe
5.4    Asia-Pacific
         5.4.1    Overview
                     5.4.1.1    Asia-Pacific Recombinant Cell Culture Supplements Market (by Product)
         5.4.2    China
         5.4.3    Japan
         5.4.4    India
         5.4.5    Australia
         5.4.6    South Korea
         5.4.7    Rest-of-Asia-Pacific
5.5    Latin America
         5.5.1    Overview
                     5.5.1.1    Latin America Recombinant Cell Culture Supplements Market (by Product)    
         5.5.2    Brazil
         5.5.3    Mexico
         5.5.4    Rest-of-Latin America
5.6    Rest-of-the-World
         5.6.1    Overview
                     5.6.1.1    Rest-of-the-World Recombinant Cell Culture Supplements Market (by Product)
         5.6.2    Middle East and Africa
         5.6.3    Others (Rest-of-the-World)

6.1    Overview
6.2    Key Developments and Strategies
         6.2.1    Business Expansions
         6.2.2    Product Launches and Developments
         6.2.3    Mergers and Acquisitions
         6.2.4    Others
6.3    Market Share Analysis (by Company)
6.4    Growth-Share Analysis (by Company)

7.1    Overview
7.2    Abcam plc.
         7.2.1    Company Overview
         7.2.2    Role of Abcam plc. in the Global Recombinant Cell Culture Supplements Market
         7.2.3    Key Customers of the Company
         7.2.4    Key Competitors of the Company
         7.2.5    Financials
         7.2.6    Analyst Perspective
7.3    BBI Solutions
         7.3.1    Company Overview
         7.3.2    Role of BBI Solutions in the Global Recombinant Cell Culture Supplements Market
         7.3.3    Key Competitors of the Company
         7.3.4    Analyst Perspective
7.4    Corning Incorporated
         7.4.1    Company Overview
         7.4.2    Role of Corning Incorporated in the Global Recombinant Cell Culture Supplements Market
         7.4.3    Key Customers of the Company
         7.4.4    Key Competitors of the Company
         7.4.5    Financials
         7.4.6    Key Insights about Financial Health of the Company
         7.4.7    Analyst Perspectives
7.5    FUJIFILM Irvine Scientific, Inc.
         7.5.1    Company Overview
         7.5.2    Role of FUJIFILM Irvine Scientific, Inc. in the Global Recombinant Cell Culture Supplements Market
         7.5.3    Key Competitors of the Company
         7.5.4    Analyst Perspective
7.6    Gemini Bioproducts, LLC
         7.6.1    Company Overview
         7.6.2    Role of Gemini Bioproducts, LLC in the Global Recombinant Cell Culture Supplements Market
         7.6.3    Key Customers of the Company
         7.6.4    Key Competitors of the Company
         7.6.5    Analyst Perspective
7.7    HiMedia Laboratories
         7.7.1    Company Overview
         7.7.2    Role of HiMedia Laboratories in the Global Recombinant Cell Culture Supplements Market
         7.7.3    Key Customers of the Company
         7.7.4    Key Competitors of the Company
         7.7.5    Analyst Perspective
7.8    InVitria
         7.8.1    Company Overview
         7.8.2    Role of InVitria in the Global Recombinant Cell Culture Supplements Market
         7.8.3    Key Customers of the Company
         7.8.4    Key Competitors of the Company
         7.8.5    Analyst Perspective
7.9    Kingfisher Biotech, Inc.
         7.9.1    Company Overview
         7.9.2    Role of Kingfisher Biotech, Inc. in the Global Recombinant Cell Culture Supplements Market
         7.9.3    Key Competitors of the Company
         7.9.4    Analyst Perspective
7.10    Lonza Group AG
           7.10.1    Company Overview
           7.10.2    Role of Lonza Group AG in the Global Recombinant Cell Culture Supplements Market
           7.10.3    Key Customers of the Company
           7.10.4    Key Competitors of the Company
           7.10.5    Financials
           7.10.6    Analyst Perspective
7.11    Merck KGaA
           7.11.1    Company Overview
           7.11.2    Role of Merck KGaA in the Global Recombinant Cell Culture Supplements Market
           7.11.3    Key Customers of the Company
           7.11.4    Key Competitors of the Company
           7.11.5    Financials
           7.11.6    Key Insights about Financial Health of the Company
           7.11.7    Analyst Perspective
7.12    Novus Biologicals, LLC
           7.12.1    Company Overview
           7.12.2    Role of Novus Biologicals, LLC in the Global Recombinant Cell Culture Supplements Market
           7.12.3    Key Customers of the Company
           7.12.4    Key Competitors of the Company
           7.12.5    Analyst Perspective
7.13    R&D Systems, Inc.
           7.13.1    Company Overview
           7.13.2    Role of R&D Systems, Inc. in the Global Recombinant Cell Culture Supplements Market
           7.13.3    Key Customers of the Company
           7.13.4    Key Competitors of the Company
           7.13.5    Analyst Perspective
7.14    Sartorius AG
           7.14.1    Company Overview
           7.14.2    Role of Sartorius AG in the Global Recombinant Cell Culture Supplements Market
           7.14.3    Key Customers of the Company
           7.14.4    Key Competitors of the Company
           7.14.5    Financials
           7.14.6    Key Insights about Financial Health of the Company
           7.14.7    Analyst Perspective
7.15    Sino Biological Inc.
           7.15.1    Company Overview
           7.15.2    Role of Sino Biological Inc. in the Global Recombinant Cell Culture Supplements Market
           7.15.3    Key Customers of the Company
           7.15.4    Key Competitors of the Company
           7.15.5    Analyst Perspective
7.16    STEMCELL Technologies Inc.
           7.16.1    Company Overview
           7.16.2    Role of STEMCELL Technologies Inc. in the Global Recombinant Cell Culture Supplements Market
           7.16.3    Key Customers of the Company
           7.16.4    Key Competitors of the Company
           7.16.5    Analyst Perspective
7.17    Thermo Fisher Scientific Inc.
           7.17.1    Company Overview
           7.17.2    Role of Thermo Fisher Scientific Inc. in the Global Recombinant Cell Culture Supplements Market
           7.17.3    Key Customers of the Company
           7.17.4    Key Competitors of the Company
           7.17.5    Financials
           7.17.6    Key Insights about Financial Health of the Company
           7.17.7    Analyst Perspective

Table 1:    Types of Cell Culture Media
Table 2:    Pricing Overview: Recombinant Cell Culture Supplements
Table 3:    Likert Scale
Table 4:    Impact Analysis of Market Drivers
Table 5:    Impact Analysis of Market Restraints
Table 6:    Impact Analysis of Market Opportunities
Table 7:    Cost of Goods Analysis for Manufacturing of Cell Therapy Per Process
Table 8:    Regulatory Scenario: Worldwide
Table 9:    Some Companies Offering Recombinant Albumin (rAlbumin) Products
Table 10:    Some Companies Offering Recombinant Insulin (rInsulin) Products
Table 11:    Some Companies Offering Recombinant Epidermal Growth Factor (rEGF) Products
Table 12:    Some Companies Offering Recombinant Interleukin Growth Factor (rILGF) Products
Table 13:    Some Companies Offering Recombinant Transferrin (rTransferrin) Products
Table 14:    Some Companies Offering Recombinant Trypsin (rTrypsin) Products
Table 15:    Some Companies Offering Recombinant Insulin-like Growth Factor (rIGF) Products
Table 16:    Some Companies Offering Recombinant Stem Cell Factor (rSCF) Products
Table 17:    Some Companies Offering Recombinant Aprotinin (rAprotinin) Products
Table 18:    Some Companies Offering Recombinant Lysozyme (rLysozyme) Products
Table 19:    Some Companies Offering Other Supplement Products
Table 20:    North America Recombinant Cell Culture Supplements Market (by Product), 2021-2032
Table 21:    Europe Recombinant Cell Culture Supplements Market (by Product), 2022-2032
Table 22:    Asia-Pacific Recombinant Cell Culture Supplements Market (by Product), 2022-2032
Table 23:    Latin America Recombinant Cell Culture Supplements Market (by Product), 2022-2032
Table 24:    Rest-of-the-World Recombinant Cell Culture Supplements Market (by Product), 2022-2032

Figure 1:    Global Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 2:    Impact Analysis of Market Drivers and Market Challenges on the Global Recombinant Cell Culture Supplements Market
Figure 3:    Global Recombinant Cell Culture Supplements Market (Share by Product), 2021 and 2032
Figure 4:    Global Recombinant Cell Culture Supplements Market (Share by Application), 2021 and 2032
Figure 5:    Global Recombinant Cell Culture Supplements Market (Share by Expression System), 2021 and 2032
Figure 6:    Global Recombinant Cell Culture Supplements Market (Share by Region), 2021 and 2032
Figure 7:    Global Recombinant Cell Culture Supplements Market
Figure 8:    Global Recombinant Cell Culture Supplements Market: Research Methodology
Figure 9:    Primary Research Methodology
Figure 10:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 11:    Initial Stages of Cell Culture
Figure 12:    Advantages of Serum-Free Media
Figure 13:    Recombinant Cell Culture Supplements and Applications
Figure 14:    Development of Biopharmaceutical Product: Cell Culture Process
Figure 15:    Global Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 16:    Number of Mergers and Acquisitions in Recombinant Cell Culture Supplements Market, 2019-2022
Figure 17:    Food and Drugs Administration (FDA) Approved Monoclonal Antibodies (mAbs), 2015-2020
Figure 18:    Clinical Development Landscape (Drug Pipeline) for Regenerative Medicine in the U.S. (February 2020)
Figure 19:    Food and Drug Administration’s Role
Figure 20:    Cell and Tissue Culture Supplies and Equipment
Figure 21:    European Union (EU) Guidelines for Animal-Derived Media
Figure 22:    Areas of Disruption in Clinical Development
Figure 23:    Positive Impact of COVID-19: Global Recombinant Cell Culture Supplements Market
Figure 24:    Segmentation of Recombinant Cell Culture Supplements Market
Figure 25:    Global Recombinant Cell Culture Supplements Market (by Product), $Million, 2021 and 2032
Figure 26:    Global Recombinant Cell Culture Supplement Market (Recombinant Albumin (rAlbumin)), $Million, 2021-2032
Figure 27:    Global Recombinant Cell Culture Supplements Market (Recombinant Albumin (rAlbumin), by Application), $Million, 2021-2032
Figure 28:    Global Recombinant Cell Culture Supplements Market (Recombinant Albumin (rAlbumin), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 29:    Global Recombinant Cell Culture Supplements Market (Recombinant Albumin (rAlbumin), by Bio-Production), $Million, 2021-2032
Figure 30:    Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin)), $Million, 2021-2032
Figure 31:    Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin), by Application), $Million, 2021-2032
Figure 32:    Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 33:    Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin), by Bio-Production), $Million, 2021-2032
Figure 34:    Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF)), $Million, 2021-2032
Figure 35:    Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF), by Application), $Million, 2021-2032
Figure 36:    Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 37:    Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF), by Bio-Production), $Million, 2021-2032
Figure 38:    Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF)), $Million, 2021-2032
Figure 39:    Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF), by Application), $Million, 2021-2032
Figure 40:    Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 41:    Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF), by Bio-Production), $Million, 2021-2032
Figure 42:    Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin)), $Million, 2021-2032
Figure 43:    Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin), by Application), $Million, 2021-2032
Figure 44:    Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 45:    Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin), by Bio-Production), $Million, 2021-2032
Figure 46:    Recombinant Trypsin (rTrypsin): Common Features
Figure 47:    Global Recombinant Cell Culture Supplements Market (Recombinant Trypsin (rTrypsin)), $Million, 2021-2032
Figure 48:    Global Recombinant Cell Culture Supplements Market (Recombinant Trypsin (rTrypsin), by Application), $Million, 2021-2032
Figure 49:    Global Recombinant Trypsin (rTrypsin) Market (by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 50:    Global Recombinant Cell Culture Supplements Market (Recombinant Trypsin (rTrypsin), by Bio-Production), $Million, 2021-2032
Figure 51:    Global Recombinant Cell Culture Supplements Market (Recombinant Insulin-like Growth Factor (rIGF)), $Million, 2021-2032
Figure 52:    Global Recombinant Cell Culture Supplements Market (Recombinant Insulin-like Growth Factor (rIGF), by Application), $Million, 2021-2032
Figure 53:    Global Recombinant Cell Culture Supplements Market (Recombinant Insulin-like Growth Factor (rIGF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 54:    Global Recombinant Cell Culture Supplements Market (Recombinant  Insulin-like Growth Factor (rIGF), by Bio-Production), $Million, 2021-2032
Figure 55:    Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), $Million, 2021-2032
Figure 56:    Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), by Application), $Million, 2021-2032
Figure 57:    Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 58:    Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), by Bio-Production), $Million, 2021-2032
Figure 59:    Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin), $Million, 2021-2032
Figure 60:    Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin), by Application), $Million, 2021-2032
Figure 61:    Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin) Market, by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 62:    Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin), by Bio-Production), $Million, 2021-2032
Figure 63:    Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme)), $Million, 2021-2032
Figure 64:    Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme), by Application), $Million, 2021-2032
Figure 65:    Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 66:    Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme), by Bio-Production), $Million, 2021-2032
Figure 67:    Global Recombinant Cell Culture Supplements Market (Others), $Million, 2021-2032
Figure 68:    Global Recombinant Cell Culture Supplements Market (Others, by Application), $Million, 2021-203
Figure 69:    Global Recombinant Cell Culture Supplements Market (Others, by Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 70:    Global Recombinant Cell Culture Supplements Market (Others, by Bio-Production), $Million, 2021-2032
Figure 71:    Global Recombinant Cell Culture Supplements (by Application)
Figure 72:    Global Recombinant Cell Culture Supplements Market (by Application), 2022 and 2032
Figure 73:    Regenerative Medicine: Present and Future State
Figure 74:    Global Recombinant Cell Culture Supplements Market (Stem Cell and Regenerative Medicine), $Million, 2021-2032
Figure 75:    Global Recombinant Cell Culture Supplements Market (by Stem Cell and Regenerative Medicine), $Million, 2021 and 2032
Figure 76:    Types of Stem Cells
Figure 77:    Global Recombinant Cell Culture Supplements Market (Stem Cell Therapies), $Million, 2021-2032
Figure 78:    Type of Cell Therapies
Figure 79:    Global Recombinant Cell Culture Supplements Market (Cell Therapies), $Million, 2021-2032
Figure 80:    Type of Gene Therapies
Figure 81:    Global Recombinant Cell Culture Supplements Market (Gene Therapies), $Million, 2021-2032
Figure 82:    Global Recombinant Cell Culture Supplements Market (by Bio-Production), $Million, 2021-2032
Figure 83:    Global Recombinant Cell Culture Supplements Market (by Bio-Production), $Million, 2021 and 2032
Figure 84:    Global Recombinant Cell Culture Supplements Market (Monoclonal Antibodies), $Million, 2021-2032
Figure 85:    Global Recombinant Cell Culture Supplements Market (Recombinant Proteins), $Million, 2021-2032
Figure 86:    Global Recombinant Cell Culture Supplements Market (Hormones), $Million, 2021-2032
Figure 87:    Global Recombinant Cell Culture Supplements Market (Vaccines), $Million, 2021-2032
Figure 88:    Global Recombinant Cell Culture Supplements Market (Other Biological Products), $Million, 2021-2032
Figure 89:    Recombinant Supplement and Respective Applications
Figure 90:    Global Recombinant Cell Culture Supplements Market (Academic and Research Application), $Million, 2021-2032
Figure 91:    Global Recombinant Cell Culture Supplements Market (by Expression System), $Million, 2021 and 2032
Figure 92:    Global Recombinant Cell Culture Supplements Market (Mammalian Expression System), $Million, 2021-2032
Figure 93:    Global Recombinant Cell Culture Supplements Market (E. coli Expression System), $Million, 2021-2032
Figure 94:    Global Recombinant Cell Culture Supplements Market (Yeast Expression System), $Million, 2021-2032
Figure 95:    Global Recombinant Cell Culture Supplements Market (Others), $Million, 2021-2032
Figure 96:    Global Recombinant Cell Culture Supplements Market (by Region), $Million, 2021 and 2032
Figure 97:    North America Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 98:    North America: Market Dynamics
Figure 99:    North America Recombinant Cell Culture Supplements Market (by Country), $Million, 2021 and 2032
Figure 100:    U.S. Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 101:    Canada Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 102:    Europe Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 103:    Europe: Market Dynamics
Figure 104:    Europe Recombinant Cell Culture Supplements Market (by Country), $Million, 2021 and 2032
Figure 105:    Germany Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 106:    U.K. Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 107:    France Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 108:    Italy Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 109:    Spain Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 110:    Rest-of-Europe Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 111:    Asia-Pacific Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 112:    Asia-Pacific: Market Dynamics
Figure 113:    Asia-Pacific Recombinant Cell Culture Supplements Market (by Country), $Million, 2021 and 2032
Figure 114:    China Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 115:    Japan Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 116:    India Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 117:    Australia Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 118:    South Korea Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 119:    Rest-of-Asia-Pacific Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 120:    Latin America Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 121:    Latin America: Market Dynamics
Figure 122:    Latin America Recombinant Cell Culture Supplements Market (by Country), $Million, 2021-2032
Figure 123:    Brazil Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 124:    Mexico Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 125:    Rest-of-Latin America Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 126:    Rest-of-the-World (RoW) Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 127:    Rest-of-the-World Recombinant Cell Culture Supplements Market (by Region), $Million, 2021-2032
Figure 128:    Middle East and Africa Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 129:    Middle East and Africa: Market Dynamics
Figure 130:    Others (Rest-of-the-World) Recombinant Cell Culture Supplements Market, $Million, 2021-2032
Figure 131:    Competitive Landscape (January 2019-June 2022)
Figure 132:    Share of Key Developments and Strategies, January 2019-June 2022
Figure 133:    Business Expansions (by Company), January 2019-June 2022
Figure 134:    Product Launches and Developments (by Company), January 2019-June 2022
Figure 135:    Mergers and Acquisitions (by Company), January 2019-June 2022
Figure 136:    Others (by Company), January 2019-June 2022
Figure 137:    Market Share Analysis of Global Recombinant Cell Culture Supplements Market (by Company), 2020 and 2021
Figure 138:    Growth-Share Analysis for Global Recombinant Cell Culture Supplements (by Company), 2021
Figure 139:    Share of Total Number of Companies Profiled
Figure 140:    Abcam plc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 141:    Abcam plc.: Overall Financials, $Million, 2018-2020
Figure 142:    Abcam plc.: Revenue (by Region), $Million, 2018-2020
Figure 143:    BBI Solutions: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 144:    Corning Incorporated: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 145:    Corning Incorporated: Overall Financials, $Million, 2019-2021
Figure 146:    Corning Incorporated: Revenue (by Segment), $Million, 2019-2021
Figure 147:    Corning Incorporated: Revenue (by Region), $Million, 2019-2021
Figure 148:    Corning Incorporated: R&D Expenditure, $Million, 2019-2021
Figure 149:    FUJIFILM Irvine Scientific, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 150:    Gemini Bioproducts, LLC : Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 151:    HiMedia Laboratories: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 152:    InVitria: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 153:    Kingfisher Biotech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 154:    Lonza Group AG: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 155:    Lonza Group AG: Overall Financials, $Million, 2019-2021
Figure 156:    Lonza Group AG: Revenue (by Segment), $Million, 2019-2021
Figure 157:    Merck KGaA: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 158:    Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 159:    Merck KGaA: Revenue (by Segment), $Million, 2019-2021
Figure 160:    Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 161:    Merck KGaA: R&D Expenditure, $Million, 2019-2021
Figure 162:    Novus Biologicals, LLC: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 163:    R&D Systems, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 164:    Sartorius AG: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 165:    Sartorius AG: Overall Financials, $Million, 2019-2021
Figure 166:    Sartorius AG: Revenue (by Segment), $Million, 2019-2021
Figure 167:    Sartorius AG: Revenue (by Region), $Million, 2019-2021
Figure 168:    Sartorius AG: R&D Expenditure, $Million, 2019-2021
Figure 169:    Sino Biological Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 170:    STEMCELL Technologies Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 171:    Thermo Fisher Scientific Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 172:    PeproTech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
Figure 173:    Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 174:    Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 175:    Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021
Figure 176:    Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021

Market Report Coverage

Global Recombinant Cell Culture Supplements Market

Base Year

2021

Market Size in 2021

$308.6 Million

Forecast Period

2022-2032

Value Projection and Estimation by 2032

$1,188.6 Million

CAGR During Forecast Period

12.24%

Number of Tables

24

Number of Pages

245

Number of Figures

176

 

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, pipeline product portfolio, and market penetration.

Companies profiled under this section include six public companies and 10 private companies.

Public companies include Abcam plc., Corning Incorporated, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., while private companies include BBI Solutions, FUJIFILM Irvine Scientific, Inc., Gemini Bioproducts, LLC, HiMedia Laboratories, InVitria, Kingfisher Biotech, Inc., Novus Biologicals, LLC, R&D Systems, Inc., Sino Biological Inc., and STEMCELL Technologies Inc.

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader to understand key recombinant cell culture supplements in the market. Additionally, it helps to understand the multiple applications for which recombinant cell culture supplements are used. Moreover, the study provides the reader with a detailed understanding of different expression systems in which recombinant cell culture supplements are used. These expression systems include mammalian, e. coli, yeast, and others.

Growth/Marketing Strategy: The global recombinant cell culture supplements market has seen major development by key players operating in the market, such as mergers and acquisitions, business expansions, and product launches and developments. The favored strategy for the companies has been business expansions. The companies are focusing on the expansion of their manufacturing facilities to optimize and enable rapid and reliable delivery of cell culture media supplements to their customers. For instance, in June 2021, Sartorius AG opened a new site in Beit Haemek, Israel, which would focus on specialty and customized cell culture media for the advanced therapies market.

Competitive Strategy: Key players in the global recombinant cell culture supplements market analyzed and profiled in the study involve recombinant cell culture supplements such as recombinant albumin, insulin, and trypsin. Moreover, a detailed competitive benchmarking of players operating in the global recombinant cell culture supplements market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as business expansions, mergers and acquisitions, and partnerships and alliances will aid the reader in understanding the untapped revenue pockets in the market.

Industry and Technology Overview

Global Recombinant Cell Culture Supplements Market: Industry Overview

The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032. The growth in the global recombinant cell culture supplements market is expected to be driven by the rising demand for cell culture supplements, increasing investment in life sciences research and development, as well as growing advantages of recombinant supplements over traditional animal-derived supplements.

Market Lifecycle Stage

The global recombinant cell culture market is increasing at a rapid pace. The growing need for animal-free supplements in cell culture applications is aiding the growth of the recombinant cell culture supplements market. Recombinant cell culture supplements play a crucial role in enhancing cell viability, maintaining a healthy culture, and customizing the cell culture in accordance with the needs of the individual.

Increasing demand for immunotherapy and stem cell and regenerative medicine research is one of the major opportunities in the recombinant cell culture supplements market. Several cell culture companies, and biopharmaceutical companies are working collaboratively on drug development and using recombinant cell culture supplements as a therapeutic means for applications in biological drugs. Furthermore, the market witnessed major mergers and acquisitions in the past four years. For instance, recently, in March 2022, Thermo Fisher Scientific Inc. acquired PeproTech, Inc., a company that specializes in the development and manufacturing of recombinant proteins, in a deal of $1.85 billion.

Figure: Global Recombinant Cell Culture Supplements Market Snapshot

Global Recombinant Cell Culture Supplements Market

Source: BIS Research Analysis

Impact

Many biopharmaceutical products are being developed by utilizing the cell culture technique. The study of cell physiology and biochemistry is made possible through laboratory cell culture, which also opens up research avenues that are challenging to pursue in vivo. Controlling variables such as the culture media, culture conditions, population density, and growth rate makes it simple to assess the effects of medications or other substances on cultured cells. Additionally, it allows analyzing the function of various genes and offers enormous potential in the field of genetics. It enables the assessment of harmful and carcinogenic chemicals on cells in the fields of oncology and virology and the comprehension of how different medications, viruses, and physical or chemical carcinogens interact. Furthermore, the recombinant cell culture has various applications, such as research on vaccines, stem cells, gene therapy, and genetic engineering, as well as the creation of protein therapies manufacturing of genetically edited proteins such as monoclonal antibodies, insulin, and hormones.

Impact of COVID-19

Due to the pandemic, governments across the globe enforced lockdowns which significantly hampered the research and clinical development of several biopharmaceutical products. Additionally, research grants were shifted toward combating SARS-CoV-2. Further, the biopharmaceutical companies, research, and academic organizations focused on the development of a novel COVID-19 vaccine. Overall, there was some disruption in the recombinant cell culture supplement supply chain and operations in 2020. However, as transportation and marketing were made more accessible, the pandemic's effects on the recombinant cell culture supplements market were minimal to non-existent. Due to the shift in emphasis toward COVID-19 testing, diagnostics, and the supply chain of serum-free or recombinant supplements for the creation of a novel vaccine for the SARS-CoV-2 virus, the companies were able to maintain their financial position.

Market Segmentation

Segmentation 1: by Product
•    Recombinant Albumin (rAlbumin)
•    Recombinant Insulin (rInsulin)
•    Recombinant Epidermal Growth Factor (rEGF)
•    Recombinant Interleukin Growth Factor (rILGF)
•    Recombinant Transferrin (rTransferrin)
•    Recombinant Trypsin (rTrypsin)
•    Recombinant Insulin-like Growth Factor (rIGF)
•    Recombinant Stem Cell Factor (rSCF)
•    Recombinant Aprotinin (rAprotinin)
•    Recombinant Lysozyme (rLysozyme)
•    Others

The global recombinant cell culture supplements market in the products segment is expected to be dominated by recombinant albumin (rAlbumin). Albumin is the major nutrient and is commonly used in all types of cell cultures. Additionally, albumin is used widely in the development of monoclonal antibodies. The increase in demand for mAbs will further increase the utilization of recombinant albumin supplements in cell culture.

Segmentation 2: by Application
•    Stem Cell and Regenerative Medicine
•    Bio-Production
•    Academic and Research Application

In 2021, the global recombinant cell culture supplements market (by application) was dominated by stem cell and regenerative medicine, with a massive market share of 47.95%. However, the fastest growing segment during the forecast period is found to be academic and research applications due to enhanced cell viability and improved batch-to-batch consistency of end products.

Segmentation 3: by Expression System
•    Mammalian
•    E. Coli
•    Yeast
•    Others

The mammalian expression system dominated the global recombinant cell culture supplements market in 2021 with a market share of 40.66%. Most biopharmaceutical companies worldwide utilize stable cell lines derived from mammalian cells to produce biologics.

Segmentation 4: by Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Rest-of-the-World

The global recombinant cell culture supplements market was dominated by North America in 2021. The growth can be attributed to the presence of prominent players in the region as well as the availability of funding and technology for recombinant cell culture supplements in the region.

Recent Developments in the Global Recombinant Cell Culture Supplements Market

•    In June 2022, Gemini Bioproducts, LLC collaborated with Avantor, Inc. to provide custom cGMP solutions to enhance the process efficiency of hydrated solutions and cell culture media to biopharmaceutical companies.
•    In May 2022, FUJIFILM Irvine Scientific, Inc. announced the completion of its new bioprocessing innovation and collaboration center in China. The new center was to enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
•    In March 2022, FUJIFILM Irvine Scientific, Inc. acquired Shenandoah Biotechnology, Inc. to further enhance and complement its cell culture solutions and expertise in bioprocessing. Furthermore, the acquisition was to provide access to Shenandoah Biotechnology, Inc.'s large portfolio of recombinant proteins, which includes cytokines and growth factors.
•    In December 2019, Sartorius AG acquired a majority stake (~50%) in the Biological Industries and further plans to acquire 20% of the shares within the next three years. This acquisition was to expand Sartorius AG's cell culture media offering and will further complement its existing product portfolio for the companies in a growing market.

Demand – Drivers and Limitations

Following are the demand drivers for the global recombinant cell culture supplements market:

•    Increasing Demand for Recombinant Cell Culture Supplements Due to their Advantages
•    Increased Funding and Investment in Research and Development for Biopharmaceutical Products in Life Sciences Sector
•    Growing Number of Mergers and Acquisitions for Expanding Recombinant Cell Culture Supplements Portfolio 
•    Push from Regulatory Bodies to Utilize Animal-Free Media Supplements in Cell Culture Process

The market is expected to face some limitations too due to the following challenges:

•    Challenging Manufacturing Process of Recombinant Proteins
•    Technical Complexities Associated with Recombinant Cell Culture Supplements

Analyst Thoughts

According to Nitish Kumar, Principal Consultant, BIS Research, "The global recombinant cell culture supplements market is an emerging market and is growing rapidly. Due to the growing demand and increasing importance of animal-free cell culture supplements, the focus of researchers and biopharmaceutical companies is now shifting toward serum-free, animal-free, or recombinant cell culture supplements. Many established companies in cell culture media supplements are entering into synergistic activities such as mergers and acquisitions and partnerships and alliances with emerging companies that are solely focused on recombinant cell culture supplements, which would help the market to grow at a faster pace in years to come.”

FAQ's

What are recombinant cell culture supplements?

Recombinant supplements are used in culture media in place of proteins that were previously produced from animals. By isolating certain genes and cloning them into an expression vector, recombinant DNA technology allows for the production of recombinant proteins. These proteins are expressed in cultivated bacteria, yeast, or mammalian cells, among other things, and most of them have human origins. The use of recombinant proteins from mammalian cells in therapies for illnesses like diabetes and cancer has changed the face of healthcare.

What kinds of new strategies are being adopted by existing market players to strengthen their market position in the industry?

The global recombinant cell culture supplements market has seen major development by key players operating in the market, such as business expansions, product launches and developments, partnerships and alliances, mergers and acquisitions, funding activities, and accreditations. According to BIS Research, business expansions and product launches and developments constitute the dominant 'contributors' strategies to further increase their growth in the global recombinant cell culture supplements market companies such as FUJIFILM Irvine Scientific, Inc., Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc. and Abcam plc. have majorly adopted business expansions, product launches and developments, and mergers and acquisitions as their key strategies.

For a new company looking to enter the recombinant cell culture supplements market, which areas could it focus upon to stay ahead of the competition?

A new entrant can focus on developing animal-free or serum-free recombinant cell culture supplements as many established companies are focusing on the recombinant supplements as key products to be used in cell culture application.

What is the USP of this report?

The following can be seen as some of the USPs of the report:

· Extensive competitive benchmarking of the top 16 players has offered a holistic view of the global recombinant cell culture supplements market

· Market ranking analysis based on product portfolio, recent developments, and regional spread

· Investment landscape including product adoption scenario, funding, and patent analysis

Who should buy this report?

Recombinant cell culture supplement providers, pharmaceutical companies, research, academic institutions, etc. should buy this report.

You may also like

Published Year:2019

Latin America Cell Culture Market - Analysis and Forecast, 2018-2025: Focus on Product Types (Consum

The Latin America cell culture market has been witnessing a steady growth. The market is...

Global Recombinant Cell Culture Supplements Market

Focus on Pricing Analysis, Product, Application, Expression System, and Region - Analysis and Forecast, 2022-2032

Contact Us

Get Free SampleSchedule a Call